Psychopathy
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
The Therapeutic Effects of Equine-Assisted Psychotherapy
Empathy, Psychopathy and Autism: Behavioural Associations and the Role of an Oxytocin Receptor Polymorphism in a Non-clinical Adult Population
Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa
Emotion Recognition Training in Antisocial Violent Offenders With Psychopathic Traits
The Role of Norepinephrine in Emotional Processing
The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention
Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates